Arete Wealth Advisors, LLC Arbutus Biopharma Corp Transaction History

Arete Wealth Advisors, LLC

  • $1.17 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.52 - $3.63 $37,800 - $54,450
15,000 New
15,000 $46,000
Q1 2023

May 01, 2023
BUY
$2.23 - $3.1 $33,450 - $46,500
15,000 New
15,000 $45,000
Q3 2022

Nov 07, 2022
BUY
$1.88 - $2.88 $28,200 - $43,200
15,000 New
15,000 $29,000
Q2 2022

Aug 15, 2022
SELL
$1.98 - $3.17 $29,700 - $47,550
-15,000 Closed
0 $0
Q4 2021

Feb 07, 2022
BUY
$3.11 - $4.61 $46,650 - $69,150
15,000 New
15,000 $58,000

Others Institutions Holding ABUS

# of Institutions
155
Shares Held
99.5M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $478M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Arete Wealth Advisors, LLC Portfolio

Follow Arete Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email